Photobiomodulation as a potential therapeutic strategy in COVID-19 management.

Abstract

Chuan-Tsung Su

The current outbreak of coronavirus disease 2019 (COVID-19) constitutes a global emergency. While numerous medications are employed in the treatment of COVID-19 patients, they may elicit a range of adverse effects. Photobiomodulation therapy (PBMT) is advocated for its noninvasive, painless, and secure biostimulative properties. Notably, recent findings indicate that PBMT has demonstrated promising clinical outcomes in COVID-19 patients. Those who received PBMT exhibited swift recovery with no discernible side effects during the clinical study. PBMT exhibits significant potential for anti-inflammatory and immunomodulatory effects, and these mechanisms are elucidated in this study. The present work suggests that PBMT holds tremendous potential for application in at-home patient care. Furthermore, PBMT can serve as an alternative and complementary therapy within the realm of clinical research practices.

PDF